Address |
Bellevue Centre West Vancouver British Columbia V7T 2X1 Canada |
Employees | - |
Website | http://www.briacell.com |
Updated | 07/08/2019 |
BriaCell Therapeutics Corp. operates as an immuno-oncology company which engages in the development of immunotherapy treatments for cancer. Its product candidate, BriaVax, is a genetically engineered whole-cell vaccine derived from a human breast cancer cell line. It is used in combination with multiple immune-modulators to powerfully trigger the immune system to recognize and eliminate cancerous cells. |